Biblio
Export 19 results:
Author Title Type [ Year
Filters: Author is Mielke, Michelle M [Clear All Filters]
“The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer's Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of Aging.”, J Alzheimers Dis, vol. 60, no. 3, pp. 819-828, 2016.
, “Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition.”, J Alzheimers Dis, vol. 53, no. 2, pp. 547-56, 2016.
, “FDG-PET and Neuropsychiatric Symptoms among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1609-16, 2016.
, “Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 53, no. 2, pp. 573-81, 2016.
, “Comparison of Gait Parameters for Predicting Cognitive Decline: The Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 55, no. 2, pp. 559-567, 2017.
, “Cortical Thickness and Depressive Symptoms in Cognitively Normal Individuals: The Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1273-1281, 2017.
, , “Ceramide Accumulation Is Associated with Declining Verbal Memory in Coronary Artery Disease Patients: An Observational Study.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1235-1246, 2018.
, “Leisure-Time Physical Activity and the Risk of Incident Dementia: The Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 63, no. 1, pp. 149-155, 2018.
, “Mediterranean Diet, Its Components, and Amyloid Imaging Biomarkers.”, J Alzheimers Dis, vol. 64, no. 1, pp. 281-290, 2018.
, “Statins and Brain Health: Alzheimer's Disease and Cerebrovascular Disease Biomarkers in Older Adults.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1345-1352, 2018.
, “Lipidomic Network of Mild Cognitive Impairment from the Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 81, no. 2, pp. 533-543, 2021.
, “Physical Activity and Trajectory of Cognitive Change in Older Persons: Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 79, no. 1, pp. 377-388, 2021.
, “Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1537-1547, 2022.
, “Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old.”, J Alzheimers Dis, vol. 90, no. 1, pp. 405-417, 2022.
, “Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 89, no. 3, pp. 943-954, 2022.
, “Traumatic Brain Injury and Risk of Alzheimer's Disease and Related Dementias in the Population.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1049-1059, 2022.
, “Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 1, pp. 241-260, 2023.
, “Mayo Normative Studies: Amyloid and Neurodegeneration Negative Normative Data for the Auditory Verbal Learning Test and Sex-Specific Sensitivity to Mild Cognitive Impairment/Dementia.”, J Alzheimers Dis, vol. 100, no. 3, pp. 879-897, 2024.
,